Chandrashekhar K. Korgaonkar, Ph.D.
Affiliations: | 2003 | University of Iowa, Iowa City, IA |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Chandrashekhar Korgaonkar"Parents
Sign in to add mentorDawn E. Quelle | grad student | 2003 | University of Iowa | |
(Molecular characterization of the ARF tumor suppressor protein.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gustin JA, Korgaonkar CK, Pincheira R, et al. (2006) Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. The Journal of Biological Chemistry. 281: 16473-81 |
Datta A, Sen J, Hagen J, et al. (2005) ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF. Molecular and Cellular Biology. 25: 8024-36 |
Mayo LD, Seo YR, Jackson MW, et al. (2005) Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. The Journal of Biological Chemistry. 280: 25953-9 |
Korgaonkar C, Hagen J, Tompkins V, et al. (2005) Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Molecular and Cellular Biology. 25: 1258-71 |
Gustin JA, Pincheira R, Mayo LD, et al. (2004) Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells. American Journal of Physiology. Cell Physiology. 286: C547-55 |
Zhao L, Samuels T, Winckler S, et al. (2003) Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Molecular Cancer Research : McR. 1: 195-206 |
Korgaonkar C, Zhao L, Modestou M, et al. (2002) ARF function does not require p53 stabilization or Mdm2 relocalization. Molecular and Cellular Biology. 22: 196-206 |
Nakamura K, Lazari MF, Li S, et al. (1999) Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor. Molecular Endocrinology (Baltimore, Md.). 13: 1295-304 |